Luteolin-enriched artichoke leaf extract alleviates the metabolic syndrome in mice with high-fat diet-induced obesity

Nutrients

Volumn 10, Issue 8, 2018, Pages

  Kwon, Eun Young ^a   Kim, So Young ^a   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Artichoke; Hepatic steatosis; Inflammation; Insulin resistance; Luteolin; Obesity

Indexed keywords

ABC TRANSPORTER G5; ABC TRANSPORTER G8; ADIPOCYTOKINE; ADIPONECTIN; ALANINE AMINOTRANSFERASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; ARTICHOKE LEAF EXTRACT; CARNITINE PALMITOYLTRANSFERASE; FATTY ACID SYNTHASE; FECES LIPID; GASTRIC INHIBITORY POLYPEPTIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE (NADP); HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; LIPOPROTEIN LIPASE; LUTEOLIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PLANT EXTRACT; PLASMINOGEN ACTIVATOR INHIBITOR 1; STEROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1A; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNINDEXED DRUG; INTERLEUKIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET INDUCED OBESITY; DIET SUPPLEMENTATION; DYSLIPIDEMIA; ENZYME ACTIVITY; FATTY ACID OXIDATION; FATTY LIVER; FECES ANALYSIS; FOOD INTAKE; GENE EXPRESSION; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; HOMEOSTASIS MODEL ASSESSMENT; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIPOGENESIS; MALE; METABOLIC SYNDROME X; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; ARTICHOKE; BILE; BLOOD; C57BL MOUSE; CHEMISTRY; COMPLICATION; DIETARY SUPPLEMENT; DRUG EFFECT; ENZYMOLOGY; INFLAMMATION; LIPID METABOLISM; LIVER; METABOLISM; OBESITY; PHYTOTHERAPY; PLANT LEAF;

ADIPOSITY; ANIMALS; BILE; CYNARA SCOLYMUS; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; DYSLIPIDEMIAS; GASTRIC INHIBITORY POLYPEPTIDE; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKINS; LIPID METABOLISM; LIVER; LUTEOLIN; MALE; METABOLIC SYNDROME; MICE, INBRED C57BL; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 85050940386     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu10080979     Document Type: Article

References (47)

1. Visscher, T.L.; Seidell, J.C. The public health impact of obesity. Annu. Rev. Public Health 2001, 22, 355-375. [CrossRef] [PubMed]
2. World Health Organizaion. Fact Sheet: Obesity and Overweight. Available online: http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (accessed on 16 February 2018).
3. Rosen, E.D.; Spiegelman, B.M. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006, 444, 847-853. [CrossRef] [PubMed]
4. Jung, U.J.; Choi, M.S. Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int. J. Mol. Sci. 2014, 15, 6184-6223. [CrossRef] [PubMed]
5. Klöting, N.; Blüher, M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev. Endocr. Metab. Disord. 2014, 15, 277-287. [CrossRef] [PubMed]
6. Feingold, K.R.; Grunfeld, C. Obesity and Dyslipidemia; MDText.com Inc.: South Dartmouth, MA, USA, 2015.
7. Kopelman, P.G. Obesity as a medical problem. Nature 2000, 404, 635-643. [CrossRef] [PubMed]
8. Chalasani, N.; Younossi, Z.; Lavine, J.E.; Diehl, A.M.; Brunt, E.M.; Cusi, K.; Charlton, M.; Sanyal, A.J. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012, 55, 2005-2023. [CrossRef] [PubMed]
9. Lattanzio, V.; Kroon, P.A.; Linsalata, V.; Cardinali, A. Globe artichoke: a functional food and source of nutraceutical ingredients. J. Funct. Foods 2009, 1, 131-144. [CrossRef]
10. Sánchez-Rabaneda, F.; Jauregui, O.; Lamuela-Raventós, R.M.; Bastida, J.; Viladomat, F.; Codina, C. Identification of phenolic compounds in artichoke waste by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2003, 1008, 57-72. [CrossRef]
11. Negro, D.; Montesano, V.; Grieco, S.; Crupi, P.; Sarli, G.; De Lisi, A.; Sonnante, G. Polyphenol compounds in artichoke plant tissues and varieties. J. Food Sci. 2012, 77, C244-C252. [CrossRef] [PubMed]
12. Wang, M.; Simon, J.E.; Aviles, I.F.; He, K.; Zheng, Q.Y.; Tadmor, Y. Analysis of antioxidative phenolic compounds in artichoke (Cynara scolymus L.). J. Agric. Food Chem. 2003, 51, 601-608. [CrossRef] [PubMed]
13. Kwon, E.Y.; Jung, U.J.; Park, T.; Yun, J.W.; Choi, M.S. Luteolin attenuates hepatic steatosis and insulin resistance through the interplay between the liver and adipose tissue in diet-induced obese mice. Diabetes 2015, 64, 1658-1669. [CrossRef] [PubMed]
14. Zhang, L.; Han, Y.J.; Zhang, X.; Wang, X.; Bao, B.; Qu, W.; Liu, J. Luteolin reduces obesity-associated insulin resistance in mice by activating AMPKα1 signalling in adipose tissue macrophages. Diabetologia 2016, 59, 2219-2228. [CrossRef] [PubMed]
15. Xu, N.; Zhang, L.; Dong, J.; Zhang, X.; Chen, Y.G.; Bao, B.; Liu, J. Low-dose diet supplement of a natural flavonoid, luteolin, ameliorates diet-induced obesity and insulin resistance in mice. Mol. Nutr. Food Res. 2014, 58, 1258-1268. [CrossRef] [PubMed]
16. Folch, J.; Lees, M.; Sloane-Stanley, G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226, 497-509. [PubMed]
17. Davidson, A.L.; Arion, W.J. Factors underlying significant underestimations of glucokinase activity in crude liver extracts: Physiological implications of higher cellular activity. Arch. Biochem. Biophys. 1987, 253, 156-167. [CrossRef]
18. Ochoa, S.; Mehler, A.H.; Kornberg, A. Biosynthesis of dicarboxylic acids by carbon dioxide fixation; isolation and properties of an enzyme from pigeon liver catalyzing the reversible oxidative decarboxylation of 1-malic acid. J. Biol. Chem. 1948, 174, 979-1000. [PubMed]
19. Walton, P.A.; Possmayer, F. Mg2-dependent phosphatidate phosphohydrolase of rat lung: Development of an assay employing a defined chemical substrate which reflects the phosphohydrolase activity measured using membrane-bound substrate. Anal. Biochem. 1985, 151, 479-486. [CrossRef]
20. Markwell, M.A.; McGroarty, E.J.; Bieber, L.L.; Tolbert, N.E. The subcellular distribution of carnitine acyltransferases in mammalian liver and kidney. A new peroxisomal enzyme. J. Biol. Chem. 1973, 248, 3426-3432. [PubMed]
21. Bentle, L.A.; Lardy, H.A. Interaction of anions and divalent metal ions with phosphoenolpyruvate carboxykinase. J. Biol. Chem. 1976, 251, 2916-2921. [PubMed]
22. Alegre, M.; Ciudad, C.J.; Fillat, C.; Guinovart, J.J. Determination of glucose-6-phosphatase activity using the glucose dehydrogenase-coupled reaction. Anal. Biochem. 1988, 173, 185-189. [CrossRef]
23. Magielse, J.; Verlaet, A.; Breynaert, A.; Keenoy, B.M.Y.; Apers, S.; Pieters, L.; Hermans, N. Investigation of the in vivo antioxidative activity of Cynara scolymus (artichoke) leaf extract in the streptozotocin-induced diabetic rat. Mol. Nutr. Food Res. 2014, 58, 211-215. [CrossRef] [PubMed]
24. Küskü-Kiraz, Z.; Mehmetçik, G.; Doǧru-Abbasoǧlu, S.; Uysal, M. Artichoke leaf extract reduces oxidative stress and lipoprotein dyshomeostasis in rats fed on high cholesterol diet. Phytother. Res. 2010, 24, 565-570. [CrossRef] [PubMed]
25. Qiang, Z.; Lee, S.O.; Ye, Z.; Wu, X.; Hendrich, S. Artichoke extract lowered plasma cholesterol and increased fecal bile acids in Golden Syrian hamsters. Phytother. Res. 2012, 26, 1048-1052. [CrossRef] [PubMed]
26. Morash, A.J.; Bureau, D.P.; McClelland, G.B. Effects of dietary fatty acid composition on the regulation of carnitine palmitoyltransferase (CPT) I in rainbow trout (Oncorhynchus mykiss). Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2009, 152, 85-93. [CrossRef] [PubMed]
27. Esser, V.; Britton, C.H.; Weis, B.C.; Foster, D.W.; McGarry, J.D. Cloning, sequencing, and expression of a cDNA encoding rat liver carnitine palmitoyltransferase I. Direct evidence that a single polypeptide is involved in inhibitor interaction and catalytic function. J. Biol. Chem. 1993, 268, 5817-5822. [PubMed]
28. Masuo, K. Roles of beta2-and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome. Int. J. Hypertens. 2010, 2010, 832821. [CrossRef] [PubMed]
29. Peng, X.R.; Gennemark, P.; O’Mahony, G.; Bartesaghi, S. Unlock the thermogenic potential of adipose tissue: Pharmacological modulation and implications for treatment of diabetes and obesity. Front. Endocrinol. 2015, 6, 174. [CrossRef] [PubMed]
30. Townsend, K.L.; Tseng, Y.H. Brown fat fuel utilization and thermogenesis. Trends Endocrinol. Metab. 2014, 25, 168-177. [CrossRef] [PubMed]
31. Samuel, V.T.; Shulman, G.I. Mechanisms for insulin resistance: Common threads and missing links. Cell 2012, 148, 852-871. [CrossRef] [PubMed]
32. Singla, P.; Bardoloi, A.; Parkash, A.A. Metabolic effects of obesity: A review. World J. Diabetes 2010, 1, 76-88. [CrossRef] [PubMed]
33. Wu, L.; Parhofer, K.G. Diabetic dyslipidemia. Metabolism 2014, 63, 1469-1479. [CrossRef] [PubMed]
34. Maples, J.M.; Brault, J.J.; Witczak, C.A.; Park, S.; Hubal, M.J.; Weber, T.M.; Houmard, J.A.; Shewchuk, B.M. Differential epigenetic and transcriptional response of the skeletal muscle carnitine palmitoyltransferase 1B (CPT1B) gene to lipid exposure with obesity. Am. J. Physiol. Endocrinol. Metab. 2015, 309, E345-E356. [CrossRef] [PubMed]
35. Zhou, L.; Xu, L.; Ye, J.; Li, D.; Wang, W.; Li, X.; Wu, L.; Wang, H.; Guan, F.; Li, P. Cidea promotes hepatic steatosis by sensing dietary fatty acids. Hepatolog 2012, 56, 95-107. [CrossRef] [PubMed]
36. Withers, D.J.; Gutierrez, J.S.; Towery, H.; Burks, D.J.; Ren, J.M.; Previs, S.; Zhang, Y.; Bernal, D.; Pons, S.; Shulman, G.I.; Bonner-Weir, S.; White, M.F. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998, 391, 900-904. [CrossRef] [PubMed]
37. Singh, A.B.; Singh, N.; Akanksha; Jayendra; Maurya, R.; Srivastava, A.K. Coagulanolide modulates hepatic glucose metabolism in C57BL/KsJ-db/db mice. Hum. Exp. Toxicol. 2012, 31, 1056-1065. [CrossRef] [PubMed]
38. Taniguchi, C.M.; Ueki, K.; Kahn, R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J. Clin. Investig. 2005, 115, 718-727. [CrossRef] [PubMed]
39. Kammoun, H.L.; Kraakman, M.J.; Febbraio, M.A. Adipose tissue inflammation in glucose metabolism. Rev. Endocr. Metab. Disord. 2014, 15, 31-44. [CrossRef] [PubMed]
40. Negrin, K.A.; Flach, R.J.R.; DiStefano, M.T.; Matevossian, A.; Friedline, R.H.; Jung, D.; Kim, J.K.; Czech, M.P. IL-1 signaling in obesity-induced hepatic lipogenesis and steatosis. PLoS ONE 2014, 9, e107265. [CrossRef] [PubMed]
41. Nonogaki, K.; Fuller, G.M.; Fuentes, N.L.; Moser, A.H.; Staprans, I.; Grunfeld, C.; Feingold, K.R. Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology 1995, 136, 2143-2149. [CrossRef] [PubMed]
42. Bastard, J.P.; Maachi, M.; Van Nhieu, J.T.; Jardel, C.; Bruckert, E.; Grimaldi, A.; Robert, J.J.; Capeau, J.; Hainque, B. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J. Clin. Endocrinol. Metab. 2002, 87, 2084-2089. [CrossRef] [PubMed]
43. Maedler, K.; Dharmadhikari, G.; Schumann, D.M.; Størling, J. Interleukin-1 beta targeted therapy for type 2 diabetes. Expert Opin. Biol. Ther. 2009, 9, 1177-1188. [CrossRef] [PubMed]
44. De Taeye, B.; Smith, L.H.; Vaughan, D.E. Plasminogen activator inhibitor-1: A common denominator in obesity, diabetes and cardiovascular disease. Curr. Opin. Pharmacol. 2005, 5, 149-154. [CrossRef] [PubMed]
45. Nasteska, D.; Harada, N.; Suzuki, K.; Yamane, S.; Hamasaki, A.; Joo, E.; Iwasaki, K.; Shibue, K.; Harada, T.; Inagaki, N. Chronic reduction of GIP secretion alleviates obesity and insulin resistance under high-fat diet conditions. Diabetes 2014, 63, 2332-2343. [CrossRef] [PubMed]
46. Pathak, V.; Vasu, S.; Flatt, P.R.; Irwin, N. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1. Diabetes Obes. Metab. 2014, 16, 357-365. [CrossRef] [PubMed]
47. Chen, S.; Okahara, F.; Osaki, N.; Shimotoyodome, A. Increased GIP signaling induces adipose inflammation via a HIF-1α-dependent pathway and impairs insulin sensitivity in mice. Am. J. Physiol. Endocrinol. Metab. 2015, 308, E414-E425. [CrossRef] [PubMed]